Antares Pharma, Inc.
New developments from Antares Pharma, Inc., outlined recently
Published in Medical Patent Week, May 13th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Antares Pharma, Inc.
Report 1: Antares Pharma, Inc. (Amex:AIS) announced receipt of Notice of Allowance from the United States Patent & Trademark Office (USPTO) covering semi-solid pharmaceutical compositions used in its Advanced Transdermal Delivery (ATD(TM)) technology. The USPTO has stated that it intends to grant patent protection which covers hormonal and non-hormonal formulations developed by Antares Pharma. The patent is expected to issue mid-year and will remain in force until...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Week
Source: Medical Patent Week (2007-05-13)
More Articles from Medical Patent Week
- Angioplasty
Abiomed Completes Enrollment of Pilot Clinical Trial for Impella 2.5 Circulatory Support System - Biotechnology
Prana Expands Senior Management Team with Appointment of Two US-based Pharmaceutical Executives - Bipolar Disorders
Brain Networks Strengthened by Closing Ion Channels - Cell Biology
IR BioSciences Appoints Celgene Executive Dr. Robert Hariri to Its Board of Directors - Cell Therapy
ThermoGenesis Announces Record Revenues and Key Executive Changes - Drug Development
Elan Reports First Quarter 2007 Financial Results - More from this issue of Medical Patent Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
